ACS Nano,
Год журнала:
2024,
Номер
18(11), С. 8143 - 8156
Опубликована: Март 4, 2024
The
complexity
and
heterogeneity
of
individual
tumors
have
hindered
the
efficacy
existing
therapeutic
cancer
vaccines,
sparking
intensive
interest
in
development
more
effective
situ
vaccines.
Herein,
we
introduce
a
nanovaccine
for
reactive
oxygen
species-augmented
metalloimmunotherapy
which
FeAl-layered
double
hydroxide
(LDH)
is
used
as
delivery
vehicle
with
dihydroartemisinin
(DHA)
cargo.
LDH
framework
acid-labile
can
be
degraded
tumor
microenvironment,
releasing
iron
ions,
aluminum
DHA.
ions
contribute
to
aggravated
intratumoral
oxidative
stress
injury
by
synergistic
Fenton
reaction
DHA
activation,
causing
apoptosis,
ferroptosis,
immunogenic
cell
death
cells.
subsequently
released
tumor-associated
antigens
adjuvant
form
generate
robust
long-term
immune
responses
against
recurrence
metastasis.
Moreover,
Fe
ion-enabled
T1-weighted
magnetic
resonance
imaging
facilitate
real-time
therapy
monitoring.
This
cancer-nanovaccine-mediated
strategy
has
potential
revolutionizing
precision
immunotherapy
landscape.
Chemical Reviews,
Год журнала:
2023,
Номер
123(11), С. 6891 - 6952
Опубликована: Май 3, 2023
All
forms
of
energy
follow
the
law
conservation
energy,
by
which
they
can
be
neither
created
nor
destroyed.
Light-to-heat
conversion
as
a
traditional
yet
constantly
evolving
means
converting
light
into
thermal
has
been
enduring
appeal
to
researchers
and
public.
With
continuous
development
advanced
nanotechnologies,
variety
photothermal
nanomaterials
have
endowed
with
excellent
harvesting
capabilities
for
exploring
fascinating
prospective
applications.
Herein
we
review
latest
progresses
on
nanomaterials,
focus
their
underlying
mechanisms
powerful
light-to-heat
converters.
We
present
an
extensive
catalogue
nanostructured
materials,
including
metallic/semiconductor
structures,
carbon
organic
polymers,
two-dimensional
materials.
The
proper
material
selection
rational
structural
design
improving
performance
are
then
discussed.
also
provide
representative
overview
techniques
probing
photothermally
generated
heat
at
nanoscale.
finally
recent
significant
developments
applications
give
brief
outlook
current
challenges
future
directions
nanomaterials.
Abstract
Cancer
immunotherapies
have
improved
human
health,
and
one
among
the
important
technologies
for
cancer
immunotherapy
is
vaccine.
Antigens
are
most
components
in
vaccines.
Generally,
antigens
vaccines
can
be
divided
into
two
categories:
pre‐defined
unidentified
antigens.
Although,
loaded
with
predefined
commonly
used,
vaccine
mixed
antigens,
especially
whole
cells
or
cell
lysates,
a
very
promising
approach,
such
obviate
some
limitations
Their
advantages
include,
but
not
limited
to,
inclusion
of
pan‐spectra
(all
kinds
of)
inducing
pan‐clones
specific
T
cells,
overcoming
heterogeneity
cells.
In
this
review,
recent
advances
based
on
whole‐tumor
either
summarized.
terms
focus
applying
water‐soluble
lysates
as
Recently,
utilizing
has
become
feasible.
Considering
that
pre‐determined
antigen‐based
(mainly
peptide‐based
mRNA‐based)
various
limitations,
developing
alternative.
Advanced Materials,
Год журнала:
2023,
Номер
36(6)
Опубликована: Сен. 19, 2023
Abstract
Insufficient
activation
of
the
stimulator
interferon
genes
(STING)
signaling
pathway
and
profoundly
immunosuppressive
microenvironment
largely
limits
effect
cancer
immunotherapy.
Herein,
tumor
(TME)‐responsive
nanoparticles
(PMM
NPs)
are
exploited
that
simultaneously
harness
STING
Toll‐like
receptor
4
(TLR4)
to
augment
via
TLR4‐mediated
nuclear
factor‐kappa
B
stimulation,
leading
increased
secretion
type
I
interferons
(i.e.,
4.0‐fold
enhancement
IFN‐β)
pro‐inflammatory
cytokines
promote
a
specific
T
cell
immune
response.
Moreover,
PMM
NPs
relieve
immunosuppression
TME
by
decreasing
percentage
regulatory
cells,
polarizing
M2
macrophages
M1
type,
thus
creating
an
immune‐supportive
unleash
cascade
adaptive
Combined
with
anti‐PD‐1
antibody,
synergistic
efficacy
is
achieved
in
both
inflamed
colorectal
noninflamed
metastatic
breast
models.
rechallenging
tumor‐free
animals
homotypic
cells
induced
complete
rejection,
indicating
generation
systemic
antitumor
memory.
These
TME‐responsive
may
open
new
avenue
achieve
spatiotemporal
orchestration
activation,
providing
promising
clinical
candidate
for
next‐generation
Advanced Functional Materials,
Год журнала:
2023,
Номер
34(43)
Опубликована: Ноя. 21, 2023
Abstract
Metal–organic
framework
(MOF)
materials
are
gaining
significant
interest
in
biomedical
research,
owing
to
their
high
porosity,
crystallinity,
and
structural
compositional
diversity.
Their
versatile
hybrid
organic/inorganic
chemistry
endows
MOFs
with
the
capacity
retain
organic
(drug)
molecules,
metals,
gases,
effectively
channel
electrons
photons,
survive
harsh
physiological
conditions
such
as
low
pH,
even
protect
sensitive
biomolecules.
Extensive
preclinical
research
has
been
carried
out
treat
several
pathologies
and,
recently,
integration
other
stents
implants
demonstrated
promising
performance
regenerative
medicine.
However,
there
remains
a
gap
between
MOF
translation
into
clinically
societally
relevant
medicinal
products.
Here,
intrinsic
features
of
outlined
suitability
specific
applications
detoxification,
drug
gas
delivery,
or
(combination)
therapy
platforms
is
discussed.
Furthermore,
examples
how
have
engineered
evaluated
different
medical
indications,
including
cancer,
microbial,
inflammatory
diseases
described.
Finally,
challenges
facing
clinic
critically
examined,
goal
establishing
directions
more
realistic
approaches
that
can
bridge
translational
MOF‐containing
(nano)materials.
Chinese Journal of Cancer Research,
Год журнала:
2023,
Номер
35(1), С. 19 - 43
Опубликована: Янв. 1, 2023
Immunotherapy
has
efficiently
revolutionized
the
treatment
of
human
neoplastic
diseases.
However,
overall
responsive
rate
current
immunotherapy
is
still
unsatisfactory,
benefiting
only
a
small
proportion
patients.
Therefore,
significant
attention
been
paid
to
modulation
tumor
microenvironment
(TME)
for
enhancement
immunotherapy.
Interestingly,
recent
studies
have
shown
that
cyclic
GMP-AMP
synthase-stimulator
interferon
gene
(cGAS-STING)
was
initially
found
as
an
innate
immune
sensor
recognize
cytoplasmic
DNA
(such
bacterial,
viral,
micronuclei,
and
mitochondrial).
It
promising
signaling
pathway
activate
antitumor
responses
via
type
I
production.
Notably,
Mn2+
be
critical
molecule
sensitize
activation
cGAS-STING
better
This
led
development
Mn2+-based
strategies
pathway.
In
this
review,
we
aimed
summarize
progress
field,
focusing
on
following
three
aspects.
First,
briefly
introduced
activation,
its
regulation
effect
immunity
cycle
discussed.
Along
with
this,
several
agonists
were
their
potential
immunotherapeutic
drugs.
Then,
basic
biological
functions
illustrated,
roles
in
activation.
Next,
systematically
reviewed
immunotherapy,
which
can
classified
by
methods
based
alone
or
combined
other
therapeutic
modalities.
We
finally
speculated
future
perspectives
field
provided
rational
suggestions
develop
therapeutics.
Advanced Materials,
Год журнала:
2024,
Номер
36(21)
Опубликована: Фев. 14, 2024
Activation
of
the
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
has
emerged
as
an
efficient
strategy
to
improve
therapeutic
outcomes
immunotherapy.
However,
"constantly
active"
mode
current
STING
agonist
delivery
strategies
typically
leads
off-target
toxicity
and
hyperimmunity.
To
address
this
critical
issue,
herein
a
metal-organic
frameworks-based
nanoagonist
(DZ@A7)
featuring
tumor-specific
near-infrared
(NIR)
light-enhanced
decomposition
is
constructed
for
precisely
localized
activation
photodynamic-metalloimmunotherapy.
The
engineered
enabled
generation
mitochondria-targeted
reactive
oxygen
species
under
NIR
irradiation
specifically
release
mitochondrial
DNA
(mtDNA)
inhibit
repair
nuclear
via
hypoxia-responsive
drugs.
Oxidized
tumor
mtDNA
serves
endogenous
danger-associated
molecular
pattern
that
activates
cGAS-STING
pathway.
Concurrently,
NIR-accelerated
zinc
ions
overloading
in
cancer
cells
further
enhance
cGAS
enzymatic
activity
through
metalloimmune
effects.
By
combining
synergistically
enhanced
triggered
by
irradiation,
facilitated
maturation
dendritic
infiltration
cytotoxic
T
lymphocytes
primary
eradication,
which
also
established
long-term
anti-tumor
immunity
suppress
metastasis.
Therefore,
developed
NIR-triggered,
agonist-free,
tandem-amplified
pathway,
thereby
offering
distinct
paradigm
Abstract
Metals
are
an
emerging
topic
in
cancer
immunotherapy
that
have
shown
great
potential
modulating
immunity
cycle
and
promoting
antitumor
by
activating
the
intrinsic
immunostimulatory
mechanisms
which
been
identified
recent
years.
The
main
challenge
of
metal‐assisted
lies
fact
free
metals
as
ion
forms
easily
cleared
during
circulation,
even
cause
systemic
metal
toxicity
due
to
off‐target
effects.
With
rapid
development
nanomedicine,
metal‐based
smart
nanosystems
(MSNs)
with
unique
controllable
structure
become
one
most
promising
delivery
carriers
solve
issue,
owing
their
various
endogenous/external
stimuli‐responsiveness
release
ions
for
metalloimmunotherapy.
In
this
review,
state‐of‐the‐art
research
progress
metal‐related
is
comprehensively
summarized.
First,
mainstream
MSNs‐assisted
will
be
delineated.
immunological
effects
certain
categorization
MSNs
different
characters
compositions
then
provided,
followed
representative
exemplar
applications
treatment,
synergistic
combination
immunotherapy.
Finally,
we
conclude
review
a
summary
remaining
challenges
associated
provide
authors'
perspective
on
further
advances.
Abstract
Cancer
nanovaccines
represent
a
promising
frontier
in
cancer
immunotherapy,
utilizing
nanotechnology
to
augment
traditional
vaccine
efficacy.
This
review
comprehensively
examines
the
current
state‐of‐the‐art
nanovaccine
development,
elucidating
innovative
strategies
and
technologies
employed
their
design.
It
explores
both
preclinical
clinical
advancements,
emphasizing
key
studies
demonstrating
potential
elicit
robust
anti‐tumor
immune
responses.
The
study
encompasses
various
facets,
including
integrating
biomaterial‐based
nanocarriers
for
antigen
delivery,
adjuvant
selection,
impact
of
nanoscale
properties
on
performance.
Detailed
insights
into
complex
interplay
between
tumor
microenvironment
responses
are
provided,
highlighting
challenges
opportunities
optimizing
therapeutic
outcomes.
Additionally,
presents
thorough
analysis
ongoing
trials,
presenting
snapshot
landscape.
By
curating
latest
scientific
findings
developments,
this
aims
serve
as
comprehensive
resource
researchers
clinicians
engaged
advancing
immunotherapy.
Integrating
design
holds
immense
promise
revolutionizing
treatment
paradigms,
provides
timely
update
evolving
landscape
nanovaccines.
Chemical Society Reviews,
Год журнала:
2024,
Номер
53(7), С. 3224 - 3252
Опубликована: Янв. 1, 2024
Neoantigens
play
a
pivotal
role
in
the
field
of
tumour
therapy,
encompassing
stimulation
anti-tumour
immune
response
and
enhancement
targeting
capability.
Nonetheless,
numerous
factors
directly
influence
effectiveness
neoantigens
bolstering
responses,
including
neoantigen
quantity
specificity,
uptake
rates
by
antigen-presenting
cells
(APCs),
residence
duration
within
microenvironment
(TME),
their
ability
to
facilitate
maturation
APCs
for
activation.
Nanotechnology
assumes
significant
several
aspects,
facilitating
release,
promoting
delivery
cells,
augmenting
dendritic
shielding
from
protease
degradation,
optimizing
interactions
between
system.
Consequently,
development
nanotechnology
synergistically
enhances
efficacy
cancer
theranostics.
In
this
review,
we
provide
an
overview
sources,
mechanisms
neoantigen-induced
evolution
precision
neoantigen-based
nanomedicine.
This
encompasses
various
therapeutic
modalities,
such
as
immunotherapy,
phototherapy,
radiotherapy,
chemotherapy,
chemodynamic
other
strategies
tailored
augment
therapeutics.
We
also
discuss
current
challenges
prospects
application
nanomedicine,
aiming
expedite
its
clinical
translation.
ACS Nano,
Год журнала:
2023,
Номер
17(23), С. 23889 - 23902
Опубликована: Ноя. 25, 2023
Development
of
a
nanoscale
drug
delivery
system
that
can
simultaneously
exert
efficient
tumor
therapeutic
efficacy
while
creating
the
desired
antitumor
immune
responses
is
still
challenging.
Herein,
we
report
use
manganese
dioxide
(MnO2)-entrapping
dendrimer
nanocarrier
to
codeliver
glucose
oxidase
(GOx)
and
cyclic
GMP-AMP
(cGAMP),
an
agonist
stimulator
interferon
genes
(STING)
for
improved
chemodynamic/starvation/immune
therapy.
Methoxy
poly(ethylene
glycol)
(mPEG)-
phenylboronic
acid
(PBA)-modified
generation
5
(G5)
poly(amidoamine)
dendrimers
were
first
synthesized
then
entrapped
with
MnO2
nanoparticles
(NPs)
generate
hybrid
MnO2@G5-mPEG–PBA
(MGPP)
NPs.
The
created
MGPP
NPs
core
size
2.8
nm
display
glutathione
depletion
ability,
favorable
Mn2+
release
profile
under
microenvironment
mimetic
condition
enable
Fenton-like
reaction
T1-weighted
magnetic
resonance
(MR)
imaging.
We
show
MGPP-mediated
GOx
facilitates
enhanced
chemodynamic/starvation
therapy
cancer
cells
in
vitro,
further
codelivery
cGAMP
effectively
trigger
immunogenic
cell
death
(ICD)
strongly
promote
maturation
dendritic
cells.
In
bilateral
mouse
colorectal
model,
nanosystem
elicits
potent
performance
strong
abscopal
effect,
greatly
improving
overall
survival
rate.
Importantly,
dendrimer-mediated
not
only
allows
coordination
respective
chemodynamic/starvation-triggered
ICD
augmented
STING
activation
boost
systemic
responses,
but
also
enables
MR
imaging,
potentially
serving
as
promising
nanoplatform
responses.